Lastly, the notable enrichment in the Toll-like receptor signaling pathway (as shown in Fig. 4M) highlights the potential role of HKDC1 in modulating immune responses and inflammatory processes, both of which are increasingly recognized as crucial factors influencing cancer development and therapeutic outcomes. Here, HKDC1 is linked to cancer.